COVID-19 Vaccination Effects on Tinnitus and Hyperacusis: Longitudinal Case study

Publication Date

12-1-2023

Document Type

Article

Publication Title

International Tinnitus Journal

Volume

27

Issue

2

DOI

10.5935/0946-5448.20230039

First Page

253

Last Page

258

Abstract

The case study explores COVID-19 vaccination connection to tinnitus and hyperacusis, considering its onset and exacerbation post vaccination. The subject is a 47-year-old woman with a history of bilateral tinnitus, and her hearing history was tracked from 2014 to 2023. An intense episode of tinnitus occurred in 2021, distinct from previous experiences post COVID-19 vaccination, second dose. Symptoms manifested as sudden onset of hyperacusis, pronounced “roar” type tinnitus, and a sudden decline in hearing. Audiometric results showed reduce thresholds in low frequencies and lower speech scores in the left ear. This escalation significantly affects speech understanding in group conditions and noisy environments. There was a gradual improvement in tinnitus and hyperacusis severity, but the subject has a greater problem with speech understanding. The subject’s journey involved visits to specialists, multiple testing including neuroimaging, naturopath consultations, and anxiety medication. It emphasizes the importance of healthcare practitioners recognizing and documenting these issues and need for timely multidisciplinary intervention and support. Further research is necessary to better understand the relationship between COVID-19, vaccination, and auditory symptoms.

Keywords

Covid-19 vaccination, Hearing loss, Hyperacusis, Speech understanding, Tinnitus

Department

Audiology

Link to Full Text

Share

COinS